| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |